The FDA placed the hold on the phase 3 PRESERVE-003 trial of the antibody candidate due to varying results between patient populations, according to an SEC notice.
of BNT316/ONC-392 for non–small cell lung cancer due to varying results in patients with squamous and non-squamous NSCLC .
Gotistobart is a next-generation anti-cytotoxic T-lymphocyte-associated protein 4 antibody candidate in late-stage clinical development for various cancer indications. PRESERVE-003 is an open-label randomized trial assessing the safety and efficacy of the agent vsas monotherapy in patients with metastatic NSCLC that progressed despite prior treatment with a programmed cell death protein 1 or programmed death ligand 1 inhibitor.
“A recent assessment of the trial data by the independent data monitoring committee identified a possible variance in population results,” according to afrom the United States Securities and Exchange Commission relating to the clinical hold. “Consequently, OncoC4 and BioNTech decided to proactively pause enrollment of new patients and informed the FDA of the possible variance for further alignment.
Patients already enrolled in the trial will continue to receive treatment. Ongoing trials of gotistobart for other indications are not affected by the hold, according to the notice. Sharon Worcester, MA, is an award-winning medical journalist based in Birmingham, Alabama, writing for Medscape Medical News, MDedge, and other affiliate sites. She currently covers oncology, but she has also written on a variety of other medical specialties and healthcare topics. She can be reached atIs Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer?
Nsclc Lung Cancer Lung Carcinoma Cancer Of The Lung Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm T Cell Small Cell Lung Cancer Small-Cell Lung Cancer Oat Cell Lung Cancer SCLC Alabama U.S. Food And Drug Administration United States Food And Drug Administration Fda Lung Lymphocytes
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trial date set in Sean 'Diddy' Combs’ sex trafficking trialDevoted to live gavel-to-gavel coverage, in-depth legal reporting, and expert analysis of the nation’s most important and compelling trials.
Read more »
Mike Madigan trial LIVE updates: Opening statements expected soon in former Illinois speaker trialJury selection expected to take days, trial expected to last months
Read more »
Mike Madigan trial live updates: Potential jurors to be interviewed Wednesday in corruption trialJury selection expected to take days, trial expected to last months
Read more »
Mike Madigan trial LIVE updates: Opening statements continue in former Illinois speaker trialOpening statements will continue Tuesday in the corruption trial of former Illinois House Speaker Michael Madigan.
Read more »
Mike Madigan trial live updates: Process to select jury for former speaker corruption trial beginsThe process to select a jury for former Illinois House Speaker Michael Madigan's corruption trial began Tuesday.
Read more »
Delphi murders trial judge to hear evidence on Odinism without jury present; Trial to start FridayAs part of the ruling, the defense team’s evidence about those theories will be presented in front of Judge Gull, but the jury will not be present.
Read more »